Literature DB >> 2681514

Twenty-four hour variation of transferrin saturation in treated and untreated haemochromatosis homozygotes.

C Q Edwards1, L M Griffen, J Kaplan, J P Kushner.   

Abstract

We studied 43 haemochromatosis homozygotes and seven normal individuals to test the hypothesis that there is an almost continuous relative deficiency of apotransferrin in treated and untreated homozygotes. Transferrin saturation was measured at 2-h intervals for 24 h while all subjects ate their usual diet. Subjects with haemochromatosis were separated into four groups based on sex and whether or not they had been iron-depleted. Nineteen treated and 11 untreated male homozygotes had mean transferrin saturation values of 70 and 81%, respectively. Five treated and eight untreated female homozygotes had mean transferrin saturation values of 71 and 69%. Normal subjects had mean transferrin saturation values of 29% (3 males) and 21% (4 females). These data demonstrate continuously high transferrin saturation values, greater than 69% in most treated and untreated male and female homozygotes, resulting in hepatic iron accumulation of non-transferrin-bound iron from the portal circulation.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2681514     DOI: 10.1111/j.1365-2796.1989.tb01411.x

Source DB:  PubMed          Journal:  J Intern Med        ISSN: 0954-6820            Impact factor:   8.989


  6 in total

1.  HFE gene mutation and transferrin saturation in very low birthweight infants.

Authors:  R F Maier; H Witt; C Bührer; E Mönch; E Köttgen
Journal:  Arch Dis Child Fetal Neonatal Ed       Date:  1999-09       Impact factor: 5.747

2.  HFE gene mutation (C282Y) and phenotypic expression among a hospitalised population in a high prevalence area of haemochromatosis.

Authors:  S Distante; J P Berg; K Lande; E Haug; H Bell
Journal:  Gut       Date:  2000-10       Impact factor: 23.059

3.  Ineffective erythropoiesis in beta-thalassemia is characterized by increased iron absorption mediated by down-regulation of hepcidin and up-regulation of ferroportin.

Authors:  Sara Gardenghi; Maria F Marongiu; Pedro Ramos; Ella Guy; Laura Breda; Amy Chadburn; YiFang Liu; Ninette Amariglio; Gideon Rechavi; Eliezer A Rachmilewitz; William Breuer; Z Ioav Cabantchik; Diedra M Wrighting; Nancy C Andrews; Maria de Sousa; Patricia J Giardina; Robert W Grady; Stefano Rivella
Journal:  Blood       Date:  2007-02-13       Impact factor: 22.113

4.  Bivariate mixture modeling of transferrin saturation and serum ferritin concentration in Asians, African Americans, Hispanics, and whites in the Hemochromatosis and Iron Overload Screening (HEIRS) Study.

Authors:  Christine E McLaren; Victor R Gordeuk; Wen-Pin Chen; James C Barton; Ronald T Acton; Mark Speechley; Oswaldo Castro; Paul C Adams; Beverly M Snively; Emily L Harris; David M Reboussin; Geoffrey J McLachlan; Richard Bean
Journal:  Transl Res       Date:  2007-11-09       Impact factor: 7.012

Review 5.  Hemochromatosis. Common genes, uncommon illness?

Authors:  Helen Harrison; Paul C Adams
Journal:  Can Fam Physician       Date:  2002-08       Impact factor: 3.275

6.  Biological variability of transferrin saturation and unsaturated iron-binding capacity.

Authors:  Paul C Adams; David M Reboussin; Richard D Press; James C Barton; Ronald T Acton; Godfrey C Moses; Catherine Leiendecker-Foster; Gordon D McLaren; Fitzroy W Dawkins; Victor R Gordeuk; Laura Lovato; John H Eckfeldt
Journal:  Am J Med       Date:  2007-11       Impact factor: 4.965

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.